The Impact of Graphene Oxide on Bone Regeneration Therapies by Hermenean, Anca et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 8
The Impact of Graphene Oxide on Bone Regeneration
Therapies
Anca Hermenean, Sorina Dinescu,
Mariana Ionita and Marieta Costache
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/63333
Abstract
Currently,  there  are  several  tissue  engineering  strategies  meant  to  overcome  the
incomplete or insufficient bone regeneration conditions offered by autologous bone
graft or surgery approaches. In the last decade, attention has been focused toward
finding the equilibrium between a suitable scaffold with osteoinductive properties, a
cell  source with evident potential to develop bone tissue and the appropriate pro-
osteogenic factors to condition the differentiation process after cell-scaffold implanta‐
tion. Consequently, this chapter aims to discuss the benefits that graphene and its
derivatives, graphene oxide (GO), bring both to the scaffold biomaterial and to the
interaction  between  the  material  and  the  cellular  component  in  order  to  create  a
favorable micro-environment for efficient osteogenic differentiation process. Several
advantages of including GO in the composition of the materials are shown in relation
to cell viability, proliferation, attachment, and osteogenic differentiation.
Keywords: graphene oxide, bone regeneration, cell-scaffold interaction, cell adhesion,
cytocompatibility
1. Introduction
New materials with outstanding osteoinductive properties and abilities to promote osteogen‐
esis at the implant site are constantly developed for bone tissue engineering applications. One
of these new-generation materials with documented pro-osteogenic effects is graphene [1–3].
Graphene and its derivatives are nanomaterials with specific physical and chemical proper‐
ties compatible with bone regeneration, and therefore, they possess high potential for bone
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tissue engineering approaches. To date, the information about graphene and its derivatives
contribution to bone tissue engineering is relatively limited. In this perspective, superior results
were reported after graphene functionalization and immobilization of the derivative on different
scaffold biomaterials. This approach was successful probably due to the fact that functional
groups can reduce the hydrophobic interactions between graphene and the cellular compo‐
nent [4], thus enhancing improved biocompatibility of the resulted material. In particular,
graphene oxide (GO) have been promoted as one of the most valuable graphene derivatives
with excellent results in bone regeneration [5, 6]. Nowadays, the beneficial effects of graphene
and  its  derivatives  are  tested  in  various  biomedical  applications—anti-cancer  therapy,
biosensors, drug delivery, and tissue engineering [7–9].
2. GO impact on material bioactivity and cytocompatibility
A very strong interconnection exists between the structural, physicochemical properties, and
cytotoxic potential of the materials. Characteristics such as the flat shape, surface charges, and
uncontrolled nanobiodegradability of graphene and its derivatives condition a relative
nanocytotoxicity that has been reported [10] and currently represents a challenge for the use
of graphene-based nanomaterials in clinical applications. Although a lot of positive observa‐
tions related to the beneficial effects that graphene and GO have on cell growth, expansion,
proliferation, and even differentiation of stem cells, caution and safety issues should still be
taken into consideration when materials designed with graphene/GO are included in practical
tissue engineering.
Most of the in vitro studies, which have aimed to evaluate different material compositions with
GO content for biocompatibility, have reported a slight decrease in cell viability after contact
with GO [11, 12]. However, cell response in contact with biomaterials can vary depending on
the GO concentration and the material form of synthesis. Chng and Pumera study from 2013
[13] revealed that GO degree of cytotoxicity was related to the carbon/oxygen (C/O) ratio and
the number and distribution of carbonyl residues on the surface of the material. Additionally,
the particular conformation adopted by the GO sheets inside a material structure can have an
impact on cell behavior in contact to the material [14]. Particularly, a higher degree of com‐
paction in GO sheets determined a lower viability in dermal fibroblasts. This decrease in
viability was also associated with the increase in the levels of reactive oxygen species (ROS)
in human dermal fibroblasts [14, 15]. Related to this, the activation of caspase-3 pro-apoptotic
marker, as well as the release of lactate dehydrogenase (LDH) by PC12 cells, was also reported
when the cells were cultured in highly condensed GO sheets materials. These observations
lead to the hypothesis that added in very high concentrations to the scaffold or distributed as
a very dense network to support material’s structure, GO could actually determine a negative
influence upon cell viability and response.
For bone tissue engineering purposes, particularly for orthopedic implants, a composite film
based on ultrahigh molecular weight polyethylene (UHMWPE) improved with 0.1–1 wt%
graphene nanoplatelets was tested for cytocompatibility with bone cells. The cytotoxicity tests
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indicated that the increase in graphene nanoplatelets concentration could decrease bone cells
viability over 5 days of culture, possibly due to the agglomeration of particles [16].
Other experiments have shown the contrary—that GO added in certain concentrations in the
material has no influence upon cell viability or in some cases even has a positive effect on cell
proliferation. In this respect, Sahu et al. [17] has published a study dedicated to thermosensitive
hydrogel with GO content in regard to cytotoxicity and concluded that the addition of GO in
the composition had no pro-inflammatory effects and that the hydrogel was biocompatible.
Studies performed on titanium substrates coated with GO [18] also confirmed that graphene
derivatives are biocompatible, present low toxicity, and a large dosage loading capacity, thus
being able to function as a carrier for delivery of therapeutic proteins.
Conversely, a series of studies highlighted the importance of functionalizing graphene-based
materials in order to minimize its potential cytotoxic effects. Graphene is hydrophobic and
easily aggregates in solutions with salts, proteins, ions that can produce toxic effects. Covalent
or non-covalent modifications can be performed in order to counteract the cytotoxic-suscep‐
tible properties of this material [19]. First, it was observed that the addition of polyethylene
glycol (PEG) to GO ensures stability in physiological solutions [20]. Another study [21]
emphasized that carboxylated graphene displays higher hydrophilicity and reduced cytotox‐
icity, due to the fact that carboxylation weakens the hydrophobic interactions between
graphene and cellular membranes [19].
Based on positive results reported on grapheme derivates, we have recently tested for
cytocompatibility nanomaterials based on polysulfone (PS) and different concentrations of
carboxylated graphene (PS/G-COOH). Preliminary observations indicated that cells displayed
a very good viability and adhesion in contact with these materials and that proliferation rates
were improved as compared with control materials (pure polymer materials) (manuscript
under revision).
In the same context, our group published a series of studies highlighting the importance of
GO present in either bidimensional (2D) or tridimensional (3D) biomaterials for cell viability
and proliferation.
When testing the cytocompatibility of chitosan/GO composite films [22], with 0.5, 1, 2.5, and
6 wt% GO content, MC3T3-E1 murine preosteoblasts adapted faster and proliferated more in
contact with the chitosan/GO biocomposites with a higher content of GO. The biocomposite
chitosan/GO 6 wt% proved to be biocompatible and displayed the most equilibrated ratio
between the pro-proliferative and cytotoxic potential. In this case, viability and proliferation
potential was assessed at 2, 4, and 7 days both quantitatively by MTT assay and qualitatively
by LiveDead assay and by means of fluorescence microscopy. Fluorescence microscopy images
revealed that cells progressively proliferated and reached confluent monolayers on all
chitosan/GO biocomposite films, but the cellular density was found to be higher on the
composite materials with 2.5 and 6 wt% GO content than that on the chitosan/GO composite
films with lower GO content or 2D control. Additionally, a particular cell distribution was
noticed for 2.5 and 6 wt% GO biomaterials, suggesting that GO could have an influence on cell
behavior and distribution. The composites with 2.5 and 6 wt% GO content registered increased
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cell proliferation than the films with low GO loading and controls, particularly after 7 days of
culture, as shown by MTT. Conversely, LDH quantification showed a significantly lower
profile for chitosan/GO 6 wt% biocomposite than for control chitosan, thus supporting the
hypothesis that increase in GO content in material’s composition positively influences cell
proliferation.
Further on, similar studies were carried out for graphene oxide/chitosan–polyvinyl alcohol
films (CS–PVA/GO) in order to determine the cytocompatibility of these materials and the
possible interference of GO with cell viability and proliferation [23]. Scanning electron
microscopy (SEM), transmission electron microscopy (TEM), and X-ray diffraction (XRD) were
first employed to assess CS–PVA/GO nanocomposites structural and surface properties. Good
GO nanosheets dispersion within the polymer matrix and excellent thermal stability and
mechanical strength were shown for these composites, while the highest tensile modulus was
obtained for CS–PVA/GO 6 wt%. During biocompatibility tests, an interesting cell distribution
was highlighted when the GO concentration increased in the composition of the nanomaterials.
Cell alignment and behavior were correlated with the observed GO nanosheets small aggre‐
gations within the polymer matrix. Simultaneously, no significant cytotoxic potential was
reported for the composites even when increasing the GO concentration to 2.5 or 6 wt% and a
general increasing profile of cell viability and proliferation was described during 7 days of in
vitro culture. Particularly, the composite material with 6 wt% GO proved to display the lowest
cytotoxic potential by levels of lactate dehydrogenase released in the cell culture media and
to favor most efficiently the proliferation of murine preosteoblasts during 1 week of culture in
standard conditions. Statistical significant differences were observed in terms of viability and
proliferation between nanomaterials with low GO content (0.5 and 1 wt%) and high GO content
(2.5 and 6 wt%).
Similar results were obtained for nanofibrous biocomposite scaffolds of PVA/GO [24] using
the same MC3T3-E1 preosteoblasts. In this case, cells were able to grow and attach to the surface
of the materials and not change in cell viability was indicated when increasing GO concentra‐
tion up to 5 wt% in the composition.
A composite with particular good results, holding promises for future biomedical application
as a filtration membrane, nanocarrier, or support for bone regeneration, is a bidimensional
film based on polysulfone (PS) and GO nanosheets [25]. In this case, PS composites with 0.25,
0.5, and 1 wt% GO were compared in terms of cytocompatibility with PS controls. Based on
special conditions of synthesis, the GO nanosheets were uniformly distributed within the PS
matrix, thus ensuring a more ordered structure, as revealed by XRD analysis. Clear improve‐
ment of thermal and mechanical properties of the composites was revealed when GO was
added in the matrix. These changes in the structure were correlated with the bioactivity tested
for PS/GO nanomaterials. Very low levels of cytotoxicity were detected during 1 week of
culture for all compositions, and no relevant increase in LDH levels was found when 0.25–1
wt% GO was added, suggesting that the low cytotoxic potential of the composite was due to
the basal cytotoxicity of the PS substrate. Conversely, quantitative data showed a slight
increase in cell viability during 7 days of in vitro culture, but statistically significant values
were obtained only for the composite with 1 wt% GO, when comparing cell viabilities at 7 and
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4 days of culture. Additionally, the tendency of cell grouping was emphasized by fluorescence
microscopy only for PS/GO 1 wt%, as compared to the other composites and to the PS
membrane [25].
Similarly, membranes based on poly(ε-caprolactone) (PCL) reinforced with GO nanoplatelets
revealed good results toward use in bone regeneration due to the improvements in bioactivity
[26]. PCL/GO nanocomposites showed better mechanical properties than PCL films due to the
fiber organization and strengthening offered by GO, reflected also in better bioactivity due to
the anionic functional groups on GO surface.
Due to the tridimensional structure of the bone, in certain bone reconstruction applications, a
tridimensional porous scaffold is required to mimic bone and to resemble the appropriate
conditions for regeneration. Thus, tridimensional materials with mechanical and physical–
structural properties close to bone were investigated for biocompatibility and potential for
bone tissue engineering. In this respect, the cytocompatibility of chitosan/GO scaffolds
improved with 0.5 and 3 wt% GO has been tested both by means of indirect and direct studies
[27]. Previous reports have shown that chitosan is particularly attractive for bone reconstruc‐
tion medical applications due to its good biocompatibility, biodegradability, and ability to
support osteoblast attachment and proliferation [28, 29]. Remarkably, the addition of GO to
the composition of the scaffolds did not affect cell viability, but even resulted in a lower
cytotoxicity of the extract collected from chitosan/GO 3 wt% after 24 h of contact with cells.
These observations were correlated with the increasing proliferation profile obtained by MTT
assay after 7 days of direct contact between murine preosteoblasts from MC-3T3 line and the
materials. The data showed that the addition of 3 wt% GO to the chitosan matrix greatly
improved the composite properties and bioactivity, suggesting that GO could have positive
effects on cell behavior and metabolic activity [27].
Another combination of chitosan (CS) and GO was used as a template to fabricate hydroxya‐
patite (HA) nanocomposites resembling bone structure [30]. CS–GO–HA and GO–HA
matrices displayed good properties to support murine fibroblast and human osteoblast-like
cells proliferation, but when compared in terms of viability and bioactivity toward minerali‐
zation, chitosan functionalized GO matrix provided better conditions for bone repair.
Preliminary positive results for tridimensional GO-containing scaffolds designed specifically
for bone tissue repair were also recently reported for gelatin–poly(vinyl alcohol) biocomposites
reinforced with GO [31]. In this case, the combination between a naturally occurring compound
(gelatin), a synthetically derived one (polyvinyl alcohol) and GO resulted in a biocomposite
with equilibrated physical–chemical properties and low cytotoxic profile that allowed murine
preosteoblasts viability.
Further tests are required to select the most appropriate biocomposites to serve as platforms
to study osteogenic differentiation and thus to validate the most promising biomaterials with
application in bone regeneration therapies.
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3. GO effects on cell adhesion
In general, it has been shown that the addition of GO favors the interaction between a cellular
component and a material substrate, thus ensuring a positive effect on cell adhesion. Several
studies [32, 33, 1] have demonstrated that bone marrow mesenchymal stem cells (BM-MSCs)
developed a fusiform phenotype with multiple elongations and focal adhesion points in
contact with graphene derivatives. These observations support the idea that GO favors
cytoskeleton development and enhances cell adhesion to the material that contains GO.
Experimental conditions used for 3D scaffolds based on chitosan ± GO or nylon ± GO [34, 2,
6] also concluded that osteoblasts or preosteoblasts adhered better in the presence of GO to
the substrate materials. The mechanism underlying GO enhancement of cell adhesion has not
been elucidated yet, but Kim et al. [35] suggested that the initiation of focal adhesions is in
direct correlation with the nanotopography conditioned by GO.
From our experience, GO also induced a positive effect on murine preosteoblasts adhesion to
polysulfone/GO biofilms [25]. A more developed F-actin cytoskeleton has been identified in
the presence of 3 wt% GO by confocal microscopy, as compared to the cell cytoskeleton
observed for pure polysulfone or plysulfone with 0.5–1 wt% GO addition.
To support this hypothesis, a substrate based on collagen and GO was developed and tested
together with rat BM-MSCs for bioactivity in terms of cell viability, cell adhesion, and cell
differentiation to bone cells [36]. An obvious dependency of F-actin fiber distribution with the
GO content in the biomaterial was reported in this case, confirming our observations.
Other studies [37] described an increased cell adhesion when using GO in conjunction with
fibronectin and titanium substrates. In this case, adhesion was evaluated by looking at focal
adhesion molecules expression and localization. Vinculin was found to be highly active in the
central and peripheral contact area of the cells cultivated in contact with fibronectin and GO.
Good adhesion of cells to their substrate is crucial for cellular processes such as survival,
growth, and activation of molecular pathways involved in proliferation. In particular, it has
been shown several times that adhesion to the material is essential to induce the molecular
program underlying osteogenic differentiation and maturation to functional osteoblasts and
osteocytes capable to produce bone-specific extracellular matrix.
4. GO benefits for cell differentiation processes
Scaffolds with different GO content have been previously reported as good substrates for
osteogenic differentiation and consequently, for bone tissue regeneration therapies. The ability
of graphene and GO to improve the characteristics of scaffold materials and to promote
mesenchymal stem cells adhesion, proliferation, and differentiation toward osteogenic
lineages has been intensely studied and demonstrated [3, 38, 1, 2, 39]. Lee et al. [33] have
reported a proportional correlation between GO presence in the substrate material and the
degree of cell osteogenic differentiation. Particularly, this study has highlighted the possibility
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that graphene-based substrates behave like concentration platforms for pro-osteogenic
induction factors. Nayak et al. [1] have also shown that GO-covered materials accelerated
osteogenic differentiation of human mesenchymal stem cells, as compared to the non-GO-
treated-substrates. They concluded that the rate of differentiation conditioned by the GO
scaffold is comparable to the osteogenic differentiation induced by specific growth factors and
inducers in a conditional media.
Great emphasis has been placed on the development of biomaterials that mimic the structure,
composition, and properties of endogenous tissue using the biomimetic method [10]. Since the
osteogenic process is based on a combination of signals that will promote the nucleation of
hydroxyapatite [40–42], it is essential that the bioengineered scaffold has properties that will
induce the assembly of bone-like apatite, resembling the natural bone [10]. Considering that
charged groups can resemble extracellular matrix proteins and induce the mineralization
process, functionalization of GO by bioactive molecules such as dopamine and carrageenan
[43] or creation of an interface by modification of GO by gelatin [42] resulted in biomimetic
mineralization of hydroxyapatite. Correlated to this enhancement in mineralization, higher
cell proliferation, adhesion, and osteogenic potential as shown by alkaline phosphatase activity
were reported for MC3T3-E1 preosteoblasts cultured in contact with GO–gelatin surface, as
compared to the negative controls [42]. Consequently, these observations can further contrib‐
ute to the development of more efficient cell–scaffold interfaces based on GO properties for
successful application in bone surgery.
Although it was confirmed by an increasing number of studies, the molecular mechanism
underlying the ability of graphene or GO to induce by itself the osteogenic differentiation
process has not yet been elucidated. Xie et al. [44] designed bidimensional and tridimensional
graphene-based substrates to comparatively evaluate the crucial molecular events taking place
during periodontal ligament stem cells differentiation to bone cells in these substrates. Bone-
specific markers such as RUNX2, collagen type I, osteocalcin were found to be upregulated at
gene and protein levels of expression in GO substrates, as a proof of differentiation. A
combination of physical and chemical properties of graphene act synergistically to control the
osteoinductive effect of graphene [44].
Since they did not show significant cytotoxicity during the biocompatibility studies, graphitic
nanomaterials based on carbon nanotubes and carboxylated graphenes were evaluated for
capacity to stimulate osteogenesis in the perspective of bone regeneration nanomedicine [45].
The study showed that the activation of the osteogenic differentiation program, synthesis of
specific bone markers, and mineral deposition was possible for murine preosteoblasts in
MC3T3-E1 cells cultivated in contact with these materials.
An interesting approach in order to evaluate the positive effects of GO on cell differentiation
to bone was to incorporate GO nanoparticles in the structure of a scaffold designed for bone
tissue reconstruction. Hybrid nanoparticles resulted from reduced GO nanosheets and
strontium metallic nanoparticles were then incorporated in poly(ε-caprolactone) matrix with
the purpose to test the composite for osteoinductive properties [46]. Increased rates of
osteoblast proliferation and differentiation were detected for the scaffold containing GO
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nanoparticles, as compared to the control, and this bioactivity was associated with the release
of strontium ions from the system.
Apart from its positive influence on cell viability and proliferation, functionalized graphene
or GO proved also to favor efficient osteogenesis. By coating fibrin on the surface of GO, a
novel nanocomposite (FGO) resulted as a potential solution for bone tissue engineering
applications. Based on the analysis of bone markers’ profile, release of calcium ions and
alkaline phosphatase activity registered in osteoblast-like cells MG-63 cultivated in contact with
this material, FGO was confirmed to have osteoinductive properties and to be a good candidate
for medical applications [47]. Following the same trend of functionalized GO, another group
of researchers [48] developed a gelatin functionalized GO composite with the purpose to use
the surface charged proteins to mimic mineralization of hydroxyapatite and to obtain func‐
tional bone tissue and matrix. The gelatin–GO surface allowed bioactivity as cell adhesion and
proliferation, and additionally, it promoted the formation of osteoid mineral matrix during
murine cells osteogenic differentiation when compared to control glass surfaces.
The success and efficiency in bone regenerative medicine applications greatly depend on the
structure and properties of the implantable biomaterials, but also on the source and type of
cells used to condition regeneration. In the past few years, attention was focused on the use of
adult stem cells that display the capacity to differentiate toward bone lineage. In this respect,
mesenchymal stem cells became most widely used for bone replacement therapies since it was
observed their preferential tendency to differentiate to osteogenic lineage when exposed to
mechanically stiff scaffolds resembling bone tissue structure. One study [49] showed that when
including GO flakes in the composition of soft collagen scaffolds, the resulted composite
acquired the necessary stiffness and properties to support MSCs differentiation to bone-like
cells. Moreover, enhanced osteogenesis was found in cells exposed to GO composite conditions
as a result of good MSCs adhesion to the substrate.
An enhanced cell adhesion to the scaffold appears to be crucial for an efficient osteogenic
differentiation process. Preosteoblasts, which were previously shown to strongly adhere to
fibronectin/GO surface (Fn-Tigra) developed on titanium materials by electrodropping [37],
were also shown to differentiate to mature osteoblasts able to produce osteocalcin, type I
collagen, and calcium during 2 weeks of culture in contact with this substrate.
Bioceramics became very important in the context of bone tissue engineering. A group of
researchers [50] designed a β-tricalcium phosphate covered in modified GO (β-TCP-GRA) and
studied the interaction between this bioceramics, GO and stem cells, for bone reconstruction.
This combination was found favorable for bone production, since the bioceramics significantly
enhanced human BM-MSCs proliferation and osteogenic differentiation, as shown by alkaline
phosphatase gene expression levels. Successful osteogenesis was also reported in the case of
graphene nanogrids, which promoted the differentiation of human mesenchymal stem cells
isolated from umbilical cord toward bone cells [51].
Mesenchymal stem cells isolated from goat cultivated on graphene-coated plates were also
used as a potential platform for testing osteogenic differentiation in the view of bone tissue
engineering [52]. This study emphasized the ability of oxidized graphene alone to induce
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osteogenesis process in goat MSCs in the absence of osteogenic inducers, thus proving the
osteoinducing character of graphenes.
However, a small number of studies have focused until present on the effect of GO on human
adipose derived stem cells (hASCs) osteogenic differentiation in 3D biomaterials designed for
bone tissue engineering [53, 35]. hASCs have revealed encouraging results for adipose and
cartilage tissue engineering and proved to be a valuable and more accessible source of adult
stem cells than MSCs isolated from bone marrow. Thus, we have developed a strategy for in
vitro differentiating hASCs inside chitosan-based biomaterials improved with 0.5–3 wt% GO
for 28 days in order to study (i) the correlation between GO concentration and the degree of
osteogenic differentiation; (ii) osteogenic markers gene expression evolution by qPCR; (iii)
osteogenic markers protein expression by confocal microscopy; and (iv) accumulation of bone-
specific extracellular matrix by histological staining in our experimental conditions (manu‐
script in preparation). Our results suggested that the degree of differentiation is strongly
influenced by the content of GO in the material and that these materials are suitable for bone
regeneration therapies.
Another hybrid scaffold between chitosan and GO was used as a template material for
biomineralization of hydroxyapatite and tested as a possible material for bone tissue engi‐
neering. This combination proved to be beneficial for cellular activity including proliferation
and attachment to the HAP–CS–GO system. Additionally, the scaffold allowed osteoblast
growth and an increasing rate of mineralization during in vitro cell differentiation, confirming
our results and the potential of chitosan/GO nanomaterials for bone regenerative therapies
[54].
In the idea of creating an experimental platform for the evaluation of graphene properties for
bone regeneration, Lu et al. [55] developed a self-supporting graphene hydrogel film (SGH),
which proved to be cytocompatible and to allow cell adhesion and proliferation.
Nevertheless, the great potential of graphene and its derivatives for biomedical applications
and their positive effects on cell viability, proliferation, adhesion, and osteogenic
differentiation process have been already well documented. At this point, the challenge
remains to elucidate the molecular pathways, which are active in the interaction between
graphene and the cellular component and to explore and maximize the potential of graphene/
GO-based biomaterials as platforms for bone repair therapies and tissue engineering.
5. In vivo GO effects during bone regeneration therapies
Regeneration of large bone defects requires development of bioactive scaffolds with distinct
properties of promoting stem cells osteogenic differentiation and inducing the in vivo new bone
formation. There are just few studies with graphene-based composite materials, which
demonstrated potential to stimulate osteogenesis in vivo (Table 1).
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Material In vivo model Post-
implant
analysis
Biological effects References
Nanocomposites of
reduced graphene
oxide (rGO) and
hydroxyapatite
(HAp) (rGO/HAp
NCs)
Rabbit
calvarial
defects
4 weeks • relative mRNA expression levels of interleukin 6 (IL-6)
and tumor necrosis factor-α (TNF-α) showed no specific
inflammatory responses in the HAp grafts and
rGO/HAp grafts
• relative micro-CT values for new bone formation were
11.68 ± 8.99, 609.30 ± 308.58 and 1157.83 Å ± 224.52 in the
control, Hap grafts, and rGO/HAp grafts
• new bone density (%)in the control, HAp grafts, and
rGO/HAp grafts were 17.66 (±8.81), 26.80 (±8.32), and
52.85 (±12.04), respectively
• conclusion: graphene-based composite materials have
potentials to stimulate osteogenesis
[56]
GO-coated titanium
implants
Mouse
calvarial
defects
8 weeks • BMP-2 delivery using GO-coated Ti found out a higher
alkaline phosphatase (ALP) activity in bone-forming
cells in vitro compared with bare Ti
• substance P (SP), which is known to recruit
mesenchymal stem cells (MSCs), was co-delivered using
Ti or GO-coated Ti to further promote bone formation
• GO-coated Ti induced dual delivery of BMP-2 and SP
and increased new bone formation on Ti implanted in
the mouse calvaria compared with other groups
[57]
Graphene-oxide-
modified
β-tricalcium
phosphate
(β-TCP-GRA)
bioceramics
Rabbit
calvarial
defects
2, 4, and
8 weeks
• micro-CT analysis showed significantly increased new
bone formation in the β-TCP-GRA group compared with
the β-TCP group;
• the volume of the newly formed bone (BV/TV ratio) of
the β-TCP-GRA group (26.12 ± 4.44% and 44.83 ± 10.82%)
was significantly higher compared with control (16.64 ±
4.57% and 30.41 ± 4.10%) at weeks 4 and 8 post-implant;
• trabecular number (Tb.N) in the β-TCP-GRA group (0.39
± 0.065 and 0.63 ± 0.102) was significantly higher
compared with control (0.25 ± 0.049 and 0.41 ± 0.05) at
weeks 4 and 8 post-implant;
• histomorphometrically analysis of the mineralization
area expressed as percentage resulting from the
fluorochrome labeling with tetracycline (TE) at 2 weeks,
alizarin red (AL)
• at 4 weeks, and calcein (CA) at 6 weeks after the
implantation surgery, showed increased % of
[50]
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Material In vivo model Post-
implant
analysis
Biological effects References
regeneration and mineralization for β-TCP-GRA group
compared with control
Graphene (GO)
flakes suspended in
fibrin gels (GO/F) for
BMP-2 delivery
Mouse
calvarial
defects
8 weeks • micro-CT examination and histological analysis with
Goldner’s trichrome staining showed that the delivery
of various doses of BMP-2 using GO/F resulted in
significantly greater bone regeneration than that using F
without GO;
• a half-dose of BMP-2 delivered by GO/F resulted in bone
regeneration similar to that resulting from a full dose of
BMP-2 delivered by fibrin gel;
[58]
Graphene
hydrogel film
Subcutaneous
sites of rats
• stimulate osteogenic differentiation of stem cells,
without additional inducer and adequate
biodegradability
[55]
Calcium silicate (CS)
ceramic reinforced
with 1.5 wt%
graphene plates (GPs)
Rabbit femur
condyle defect
1–3
months
• bone–implant contact ratio reached 84.3 ± 7.4% for GPs/
CS coating and 79.6 ± 9.4% for CS coating after 3 months
implantation
[59]
Table 1. Platforms to study in vivo bone regeneration therapies using graphene-based biomaterials.
Up to date, there is a small number of in vivo studies investigating the ability of graphene-
based nanomaterial platforms to induce and support production of functional de novo bone
tissue when practical approaches in bone regenerative medicine require it. Although the
implications and benefits for patients experiencing bone defects are of great importance,
research toward validation of novel bioimplantable materials designed for bone repair
advances in small steps due to safety and ethical requirements. Graphene and its derivatives
hold great promise for the synthesis of efficient osteoinductive materials and in-depth research
looking at the interplay between graphene effects and molecular pathways active in bone
formation will contribute to bringing graphene from bioengineering labs to clinical practice.
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